T1	Participants 40 85	clozapine-treated patients with schizophrenia
T2	Participants 384 429	clozapine-treated patients with schizophrenia
T3	Participants 494 539	clozapine-treated patients with schizophrenia
T4	Participants 906 943	Nineteen patients completed the study
T5	Participants 1322 1367	clozapine-treated patients with schizophrenia
T6	Participants 1539 1566	patients with schizophrenia
